Solventum Corporation (SOLV) Enterprise Value (EV): $17.88B
The enterprise value (EV) for Solventum Corporation (SOLV) is $17.88B as of Friday, June 12, 2026.
SOLV Enterprise Value (EV) Metrics
ENTERPRISE VALUE (EV)
$17.88B
SOLV Competitors' Enterprise Value (EV)
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | $17.88B |
| Align Technology, Inc. (ALGN) | $12.64B | $10.36B |
| Baxter International Inc. (BAX) | $10.58B | $17.84B |
| Hologic, Inc. (HOLX) | $16.97B | $15.94B |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | $12.95B |
| Tempus AI, Inc. (TEM) | $8.65B | $10.50B |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | $9.26B |
| Moderna, Inc. (MRNA) | $19.70B | $10.79B |
| Hims & Hers Health, Inc. (HIMS) | $6.44B | $8.34B |
| BioNTech SE (BNTX) | $22.39B | $14.31B |
Enterprise Value Calculation
Market Cap
$13.72B
Total Debt
$5.04B
Cash
$878.00M
Enterprise Value
$17.88B
EV-Based Valuation Multiples
Why use EV instead of Market Cap?
- EV accounts for debt - an acquirer must pay or assume it
- EV deducts cash - the acquirer effectively receives it
- EV enables fair comparison of companies with different capital structures
- EV-based ratios (EV/EBITDA, EV/Sales) are capital structure neutral
Solventum Corporation Enterprise Value (EV) Formula & Definition
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation Enterprise Value (EV) FAQ
- What is the enterprise value (EV) for Solventum Corporation (SOLV)?
- The enterprise value (EV) for SOLV stock is $17.88B.
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson